Screener
Tango Therapeutics TNGX Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $347.7M+731% | $159.97M+162% | $112.28M+61.5% | $60.91M+9.3% | $41.84M-22.7% | ||
| $668.43M+372% | $222.01M+40.3% | $230.86M+22.5% | $94.47M-60.7% | $141.51M-47.7% | ||
| $1.03B+443% | $392.33M+74.4% | $353.76M+32.8% | $163.78M-45.6% | $190.1M-42.1% | ||
| $6.09M-21.7% | $6.38M-15.4% | $6.87M-15.2% | $7.35M-14.5% | $7.79M-14.4% | ||
| $1.07B+351% | $435.79M+58.9% | $398.69M+26.0% | $210.14M-40.4% | $237.89M-37.6% | ||
| $20.3M-49.3% | $14.33M-60.1% | $21.68M-43.2% | $18.44M-50.9% | $40.03M-8.8% | ||
| $49.35M-52.1% | $44.29M-58.8% | $52.51M-55.1% | $50.11M-59.3% | $102.94M-23.1% | ||
| 400M0.0% | 400M+100% | 200M+185,085% | 400M+100% | 400M+100% | ||
| -$704.01M-21.3% | -$648.67M-19.8% | -$603.15M-20.3% | -$564.4M-21.7% | -$580.29M-33.5% | ||
| $1.02B+659% | $391.51M+135% | $346.18M+73.5% | $160.03M-30.2% | $134.95M-45.5% | ||
| $1.07B+351% | $435.79M+58.9% | $398.69M+26.0% | $210.14M-40.4% | $237.89M-37.6% |
FAQ
- What are Tango Therapeutics's total assets?
- Tango Therapeutics (TNGX) holds $1.1B in total assets, up 351.4% year over year.
- How much debt does Tango Therapeutics have?
- Tango Therapeutics carries $32.0M in total debt against $1.0B of shareholders' equity, a debt-to-equity ratio of 0.03.
- How much cash does Tango Therapeutics have?
- Tango Therapeutics holds $347.7M in cash and equivalents.
- Can Tango Therapeutics cover its short-term obligations?
- Its current ratio is 50.82 — current assets exceed current liabilities.
- Where does Tango Therapeutics's balance sheet data come from?
- Every line is extracted from Tango Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
